Market Research Blog

According to the latest research by Future Market Insights, Transplant Monitoring Kits Market is expected to witness robust growth with 4-5% CAGR during the forecast period from 2021 to 2031.

The Transplant Monitoring Kits will show growth due to the rising organ transplants globally and an increased number of donors to support the recipients’ transplantation. Therefore, growth at a significantly high CAGR will be expected soon.

What is driving the Demand for Transplant Monitoring Kits?

The rising transplants globally are giving a major driving factor for the requirement of transplant monitoring kits. Among transplant recipients, non-adherence to immunosuppressive medications is a major cause of antibody-mediated rejection, which leads to graft loss.

Immunosuppressant non-adherence also contributes to the increased healthcare costs associated with acute rejection treatment, additional hospitalization, and kidney transplantation re-dialysis. Therefore, it is crucial to monitor post-transplantation who require long-term pharmacotherapy and prevent non-adherence.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13879

Previous studies have reported that approximately 14–36% of kidney transplant recipients are non-adherent to immunosuppressive medications. The immune system is inclined to attack foreign organisms introduced to the body, and the body interprets a new organ as foreign.

Also, there has been significant growth in stem cell transplants for treating chronic diseases which will drive the market.

Which factors are likely to augment the Growth of the Transplant Monitoring Kits Market?

According to a study, end-stage organ failure is estimated to affect more than six million people worldwide. Advancements in surgical techniques, immunosuppression, donor-recipient matching, and antimicrobial agents have all contributed to increasing patient success during transplant procedures.

Close monitoring of patients is essential after a transplant to ensure the body is not rejecting its new organ. The transplant patients usually receive therapeutic drugs post-transplant to help their bodies accept the new organ and remain healthy.

These therapeutic drugs require monitoring to make sure the patient is receiving the correct dosage for the greatest benefit without negative side effects or complications. As transplantation is the most favourable therapy for end-stage disease, the risk of rejection remains a constant concern.

Allograft rejection leads to a high risk of graft dysfunction, accompanied by a significantly higher probability of chronic failure and graft loss. This causes re-hospitalization and prolonged therapy or maybe death. Therefore it’s important to monitor the post-transplant.

Who are the Key Manufacturers and Suppliers of Transplant Monitoring Kits?

Some of the leading manufacturers and suppliers of Transplant Monitoring Kits include

• CareDx Inc.
• Thermo Fisher Scientific
• QIAGEN
• Hologic Inc.
• Eurofins Scientific
• JETA Molecular BV.
• ELITech Group SAS
• NateraInc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13879

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to the latest research by Future Market Insights, stress tracking devices market is set to experience positive growth during the year 2021-2031. The global stress tracking devices is witnessing demand every year as stress become apparent each year.

Stress Tracking Devices Market study by “Future Market Insights” provides details about the market dynamics affecting the market, Covid-19 Impact, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

Get a Sample Copy of Report – https://www.futuremarketinsights.com/reports/sample/rep-gb-13877

This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in fine points with solutions and suggestions that may affect the market in near future. Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments.

The report Stress Tracking Devices Market gives varied description about the segmentation of the market on the basis of segmented Dosage, Route of Administration and Application, and leads with a descriptive structure of the trends and restrictions of the various segments and sub segments. It also provides the market size and estimates a forecast from the year 2018 to 2028 with respect to major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Stress Tracking Devices Market.

The report facilitates in determining and interpreting the key market players, portfolios with necessary information such as company profiles, components and services offered, financial information of past few years, key developments in past few years, that helps in constructing strategies to gain competitive advantage in the long run. The report also analyzes factors affecting Stress Tracking Devices Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend.

Leading Stress Tracking Devices Market Players:

• Oura Health Oy.
•  WHOOP
• NeuroSky
• Garmin Ltd
• Fitbit Inc.
• Apple Inc.
• SAMSUNG
• Pebble Technology Corp.
• Google Inc.
• Xiaomi Technology Co. Ltd.
• Jawbone and Nike.

Key Elements that the report acknowledges:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance

Request Table of Content for this Insight – https://www.futuremarketinsights.com/toc/rep-gb-13877

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Sales in the global Bioimpedance Devices Market are slated to top US$ 492.1 Mn in 2022. Expanding at a healthy 6.4% CAGR, the market size is projected to total US$ 715.1 Mn by 2028.

Increasing cases of CKD diseases are expected to contribute to the growth of the Bioimpedance Devices Market throughout the forecast period. Chronic kidney disease (CKD) is a medical condition that can be characterized by gradual loss of kidney function over time. As per the National Kidney Foundation, Inc., 30 million American adults have Chronic Kidney Disease and millions of others are at high risk of developing CKD.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-5563

The Glomerular filtration rate (GFR) is the best overall index for studying kidney function. Bioelectrical impedance or Bioimpedance is used for improved estimation of glomerular filtration rate in non-diabetic patients with chronic kidney disease and also to estimate muscle mass. Bioelectrical impedance analysis (BIA) can also be used to measure appendicular lean mass (ALM).

The performance of these equations that include ALM BIA to estimate renal inulin clearance (GFR INU) can be compared with demographic variables and further used for modifications in diet for renal disease (MDRD) treatment.

Widespread online marketing channels have tremendously increased the sale of portable as well as hand-held Bioimpedance devices in recent years. For Instance, a research study estimated that in 2015, approximately 70% of the population in the U.S. depended on online shopping portals for buying different items.

Vendors operating in the Bioimpedance devices market are focusing on promotional strategies and online marketing to ensure better access to their devices and increase sales. Devices offered online also help vendors cut on operational and distribution costs.

The online marketing channel also allows vendors to offer information about devices in their portfolio and gain access to both global and local markets. In addition, these online marketing websites provide a broad selection of high-quality Bioimpedance systems at more affordable costs.

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-5563

Scope of the Report

Majority of the manufacturers in the Bioimpedance Devices makers are focusing on developing products that are portable and affordable. The popularity of portable Bioimpedance devices is increasing due to its various advantages. For instance, Bioimpedance Devices are noninvasive, reasonable, safe and easy to operate.

These devices are light in weight and thus, are extensively used in home-based healthcare settings for monitoring health of the entire family. All these factors, cumulatively, are expected to drive the demand for portable Bioimpedance devices during the forecast period. Portable/ Hand-held Bioimpedance devices are also tremendously being opted by people for traveling purposes.

For instance, the demand for ImpediMed SFB7, which is a hand-held Bioimpedance device, is increasing as this device is easy to carry. Technological advancements to enhance the quality of Bioimpedance devices and increase patient compliance are also projected to drive the growth of the market over the forecast period.

Multiple-frequency Bioimpedance Devices are highly preferred because these devices can measure impedances in various frequencies. This provides a better and efficient estimation of fat free mass, total body water and intra and extra cellular water.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-5563

Single frequency Bioimpedance devices can calculate fat free mass and total body water but these devices are not capable of estimating intra and extra cellular body water. Increasing popularity and growing awareness about multiple-frequency Bioimpedance devices is expected to boost market growth for Bioimpedance devices over the forecast period.

FMI has segmented the global Bioimpedance Devices market by product type, modality and end user. The Bioimpedance Devices market, by product type, is segmented into Single-frequency Bioimpedance Devices and Multiple-frequency Bioimpedance Devices. By Modality, the Bioimpedance devices market is segmented into Wired Bioimpedance Devices and Wireless Bioimpedance Devices.

Bioimpedance Devices, by end users, are segmented into Hospitals, Specialty Clinics, Rehabilitation Centers and Others. Region-wise segmentation includes North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. The wired Bioimpedance devices segment in the Bioimpedance Devices market is expected to witness a significant growth during the forecast period.

The report tracks some of the key companies operating in the Bioimpedance Devices market, including General Electric Company, Omron Corporation, Fresenius Medical Care, ImpediMed Limited, SELVAS AI Inc., Tanita Corporation, RJL Systems, Inc., Maltron International Ltd., Bodystat Limited and SMT Medical GmbH.

Buy Now@ https://www.futuremarketinsights.com/checkout/5563

Explore FMI’s Extensive ongoing Coverage on Healthcare

EMG Biosensors Market – According to the latest research by Fact.MR, EMG biosensors market is set to experience steady growth during the year 2021-2031.

Interchangeable Biosimilars Market – According to the latest research by Future Market Insights, the interchangeable biosimilars market is set to experience 6% growth during the year 2021-2031.

Compounded Bioidentical Hormone Therapy Market – According to the latest research by Future Market Insights, Compounded Bioidentical Hormone Therapy market is expected to grow at a CAGR of 5.2% during the forecast period.

Bioprocess Containers & Fluid Transfer Solutions Market – According to the latest research by Future Market Insights, the bioprocess containers & fluid transfer solutions market is set to witness a 14.7% growth during the year 2021-2031.

Topical Bioadhesives Market – According to the latest research by Future Market Insights, Topical Bioadhesives Market is set to experience growth during the year 2021-2031. The demand for topical bioadhesives increasing due to vast applications in various industries segments.

Airlift Bioreactors Market – According to the latest research by Future Market Insights, the airlift bioreactor market is set to witness positive growth of CAGR 11% during 2021-2031.

Bioimpedance Spectroscopy Market – According to the latest research by Future Market Insights, Bioimpedance spectroscopy market is set to witness a 9.3% growth during the year 2021-2031.

Subcutaneous Biologics Market – Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology.

Bioartificial Renal Assist Devices Market – This Bioartificial Renal Assist Devices market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape.

Rocking Bioreactors Market – A bioreactor is a device in which a biological reaction using culture is carried on. This bioprocess using bioreactor helps in the growth of cells or tissues.

The global intrauterine insemination (IUI) devices market has witnessed a marginal slump in 2020, which can be attributed to the ongoing covid-19 outbreak. Restrictions on production facilities, and the redirection of healthcare resources to handle the pandemic has hurt short-term market prospects. However, the long-term prospects of the market remain bullish, with a new study by Future Market Insights (FMI) estimating the market to grow at nearly 3.8% CAGR.

Future Market Insights in its new report has projected positive growth prospects for the poultry diagnostics market for the assessment period between 2020 and 2030. High consumption of chicken on a global scale and increasingly strict food safety standards in developed countries will held aid growth.

Widespread outbreaks of infectious diseases such as avian influenza is a key factor driving the demand for diagnostic infrastructure in the poultry industry. Also, awareness campaigns by public and private bodies about avian diseases among poultry farmers is positively influencing the industry.

Furthermore, concerns over food security and investments by governments and international bodies towards the intensive farming sector will drive cultivation of poultry. This will also support the demand for poultry diagnostics in the long-term.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12773

Key Takeaways

• ELISA tests are expected to continue holding major market share through 2030, owing to superior accuracy and cost efficiency.
• Diagnostics for avian influenza has been estimated to reflect higher market share on the back of widespread incidences in developing countries.
• Newer ailments such as mortality syndrome are expected to generate lucrative opportunities in terms of product development and interest from the veterinary sector.
• Virology services are expected to be a major contributor to the market owing to higher risk from viral infections for human consumers.
• South Asia & Pacific, will reflect fast growth, with poor hygiene standards in developing nations. North America will continue to hold larger market share, owing to superior infrastructure.

Insights on the Coronavirus Impact

As the covid-19 outbreak continues to wreak havoc on the global economy, the poultry diagnostics market is expected to also be adversely impacted during the crisis period. While chickens and other poultry birds are not at risk to the virus, the pandemic is likely to hurt consumption, logistics, and sales of birds. This can be largely attributed to strict regulations on the food service businesses.

These factors are expected to reduce chicken stocks in the poultry industry for the short term, which in turn will reduce the demand for diagnostic tools and infrastructure in the industry. The market is likely to recover strongly towards 2021, as demand for poultry products picks up. Strict food safety laws and concerns over other strains of coronavirus will aid market developments.

Market Competitiveness

Market leaders in the poultry diagnostic industry include but are not limited to Agrobiotek Internacional, Bioneer Corporation, Affinitech Ltd., Zoetis Inc., Biochek, Thermo Fisher Scientific, Bioingentech Biotechnologies Inc., Qiagen N.V., Bionote Inc., Megacor Diagnostik GmbH, and Idexx Laboratories Inc.

Market participants are increasingly focused on the product research with the aim of developing and launching improved testing tools for faster and accurate results. In addition, strategic industry collaborations and acquisitions are being used to build a foundation in a moderately competitive landscape.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12773

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

ESOMAR-certified Future Market Insights (FMI) has recently published an exhaustive yet unbiased analysis of the global Gaucher and Pompe disease ERT market providing insights on key growth trends through 2030.

As the global burden of genetic disorders such as Gaucher disease, Fabry disease, Pompe disease and other abnormalities rise, healthcare providers are scrambling to develop potential therapeutic approaches to offset their impacts.

According to the National Gaucher Foundation, one in every 450 people belonging to the Ashkenazi Jewish community suffer from Type-1 Gaucher disease, the most prevalent form, thereby opening up credible growth prospects for the future.

Key Takeaways

• Gaucher and Pompe Disease ERT market to expand at 5.6% value CAGR through 2020
• Type-1 non-neuronopathic Gaucher disease to remain key treatment area, accounting for over 90% revenue by 2020-end
• Parenteral ERT administration to be most frequent, attributed to high demand for precision-based medicine
• Online pharmacies gaining credible impetus, expanding at over 7% CAGR through 2030
• Europe to retain lucrativeness, North America to be the 2nd largest market by 2030

“Increasing regulatory approvals by government authorities is paving way for the entry of prominent enzyme replacement therapy providers, thus generating immense revenue prospects across promising markets,” concludes the FMI analyst.

To remain ‘ahead’ of your competitors, request for a sample 

COVID-19 Impact Analysis

As healthcare organization reorient their resources to fight the coronavirus pandemic, the market for Gaucher & Pompe Disease ERT experienced a substantial blip in the initial months, with treatment sessions declining significantly across several countries.

For instance, until July 2020, Spain recorded a 25% decline in enzyme replacement therapy sessions amongst people suffering from Type-1 and Type-3 Gaucher Disease respectively. This largely occurred as a consequence of rescheduling treatments at a later date.

In the United States, hospital visits to avail ERT have registered considerable decline for avoiding exposure to COVID-19 patients. As a result, patient self-administration at home have burgeoned. Furthermore, the pandemic has provided an opportunity to undertake research on lysosomal dysfunction and disease pathogenesis which would enhance clinical care.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-12771

Competitive Landscape

Prominent players operating in the Gaucher & Pompe Disease ERT landscape include Shire PLC, Ultragenyx Pharmaceuticals Inc., Sigma-Tau Pharmaceuticals Inc., Pfizer Inc., Alexion Pharmaceuticals Inc., Sanofi SA, Merck KGaA, Tadeka Pharmaceuticals, AbbVie Inc. and BioMarin Pharmaceutical Inc. to name a few.

Manufacturers rely on introduction of novel technologies to advance effective ERTs for numerous genetic conditions. For instance, in October 2018, the U.S Food & Drug Administration approved Sigma-Tau Pharmaceuticals’ (Lediant Biosciences) RevcoviTM injection for treating adenosine deaminase severe combined immune deficiency (ADA-SCID).

Likewise, Sanofi SA markets the Cerezyme® ERT ­injections through its Genzyme subsidiary, which offers a long term efficacy to elderly and pediatric patients suffering from Type-1 Gaucher Disease, and is the only known long-term cure for the condition.

More Insights on FMI’s Gaucher and Pompe Disease ERT Market Report

Future Market Insights, in its new report, offers an unbiased analysis of the global Gaucher and Pompe Disease ERT market, analyzing historical demand from 2015-2019 and forecast statistics for 2020-2030. The study reveals growth projections on the Gaucher and Pompe Disease ERT Market on the basis of therapeutic condition (Gaucher disease and Pompe disease), route of administration (oral and parenteral) and distribution channel (hospital pharmacies, specialty treatment pharmacies, retail pharmacies and online pharmacies) across seven prominent regions.

Key Segments

Therapeutic condition

• Gaucher Disease
• Type 1 (non-neuropathic)
• Type 2 (acute infantile neuronopathic)
• Type 3 Gaucher disease (chronic neuronopathic)
• Perinatal lethal Gaucher disease
• Cardiovascular Gaucher disease
• Pompe Disease
• Classic infantile-onset
• Non-classic infantile-onset
• Late-onset

Route of Administration

• Oral
• Parenteral

Distribution Channel

• Hospital Pharmacies
• Specialty Treatment Pharmacies
• Retail Pharmacies
• Online Pharmacies

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/12771

Region

• North America (U.S & Canada)
• Latin America (Brazil, Mexico, Argentina & Rest of LATAM)
• Europe (U.K, Germany, France, Spain, Italy, Russia & Rest of Europe)
• East Asia (China, Japan & South Korea)
• South Asia (India, Thailand, Indonesia, Malaysia & Rest of South Asia)
• Oceania (Australia & New Zealand)
• Middle East & Africa (GCC, South Africa, Turkey & Rest of MEA)

Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. The market is witnessing surging demand in the field of pharmacy and cosmetics.

The rising incidence of diseases such as cancer, diabetes, migraine, and others and the need to accurately administer medications are driving the market. Additionally, the demand for minimally invasive and painless treatment methods is expected to bode well for the market.

The report uncovers hidden growth opportunities. It also highlights potential threats to the market players. Some of the key takeaways from the report are highlighted below.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2750

Key Takeaways from the Report

• Solid microneedles are expected to lead the market during forecast period of 2020-2030 among product type
• Hospitals are the leading end users of microneedle drug delivery systems, with specialty clinics gaining popularity.
• Specialty clinics are expected to grow at an accelerated rate as one of the key end users of microneedle drug delivery systems
• North America is the largest market for microneedle drug delivery systems. Along with Europe, it is expected to cover more than 70% of the market by end of 2030.
• East Asia is expected to be the fastest growing regional market during the next decade.

Covid 19 Restricting Pace of Growth

The onset of pandemic has disturbed the entire business ecosystem. With productions coming to a halt and supply chains disrupted due to lack of transport, manufacturers of microneedle drug delivery systems are impacted in a big way.

Also, because of several restrictions by governments like social distancing, doctors and practitioners are choosing to avoid any surgical treatments which are not absolutely and immediately necessary.

Furthermore, cosmetic field which is another major user of microneedle drug delivery systems is also impacted as almost all treatments under their umbrella are considered to be not urgent.

Who is winning?

The key market players in microneedle drug delivery systems market include the 3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation, Microdermics, Inc., TheraJect Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co., Ltd., Small Lab and AdminMed Nano BioSciences LLC

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2750

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario